Skip to content
Search

Latest Stories

DH issues supply disruption notice for six oral contraceptive brands

The Department of Health and Social Care (DH) has issued a medicine supply notification for six oral contraceptive tablets of various brands.

The following oral contraceptive preparations are currently out of stock.


Product affectedIngredientsAnticipated Resupply DateManagement Advice
BrevinorEthinylestradiol/norethisterone 35microgram/500 microgram tabletsEarly January 2021No exact equivalent available
EloineEthinylestradiol/ drospirenone

20 microgram /3mg tablet

October 2020Unlicensed imports of Eloine have been sourced, lead times vary
NoriminEthinylestradiol/norethisterone 35microgram/1mg tabletsEarly January 2021No exact equivalent available
SynphaseEthinylestradiol/norethisterone/ 35microgram/500microgram and

35microgram/1mg tablets

Early January 2021Unlicensed imports of Synphase tablets have been sourced; lead times vary.
YiznellEthinylestradiol/drospirenone 30microgram/3mg tabletsNovember 2020Equivalent alternatives with same composition remain available from suppliers of following brands: Dretine, Yacella, Yasmin, Ellaite and Lucette.
ZoelyEstradiol/nomegestrol 1.5mg/2.5mg tabletsMid October 2020No exact equivalent available

The importers including Clinigen, Mawdsley’s Unlicensed, and Target Healthcare have confirmed that they can source unlicensed imports of Synphase tablets.

Community pharmacists can reach Alium, Mawdsley’s Unlicensed, Target Healthcare, and Durbin for unlicensed imports of Eloine tablets.

There is currently no listing on dm+d for the imported product for prescribers to select using their prescribing systems so an EPS prescription for unlicensed Synphase tablets cannot be issued.

If a prescriber wishes to prescribe an unlicensed import, an FP10 paper prescription should be issued as ‘Ethinylestradiol/norethisterone/ 35microgram/500microgram and 35microgram/1mg tablets (Special Order)‘ and endorsed by the pharmacy as a non-Part VIIIB special.

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Cat Smith MP Leads Call for Urgent Action

Health minister Wes Streeting

Pic credit: Getty Images

Urgent review into medicine shortages needed, ministers tell Streeting

Health minister Wes Streeting has been urged by 45 MPs to call an urgent review into medicine shortages that is impacting the health and safety of patients.

The news comes on the back of the death David Compton, a 44-year-old man who fell and suffered a heart attack which has been linked to him not being able to get medication for epilepsy.

Keep ReadingShow less